Biology subjects

Wing, Y. K.

Publications and source records attributed to Wing, Y. K..

3 recordsLinked to original sources

bioRxiv2024

INSIHGT: Accessible multimodal systems biology with quantitative molecular phenotyping in 3D

Biological systems are complex, encompassing intertwined spatial, molecular and functional features. However, methodological constraints always limit the completeness of information that can be extracted. Here, we report the development of INSIHGT, a minimally perturbative, accessible and cost-efficient three-dimensional (3D) spatial biology method utilizing superchaotropes and host-guest chemistry. This allows highly multiplexed and multi-modal readout of tissue biomolecules in biological systems up to centimeter scales, permitting radio-histological correlation of phosphorylated alpha-synuclein pathologies in human hemi-brainstem. The homogeneous penetration permits reliable semi-quantitative signals in 3D compared to reference signals. Diverse antigens, mRNA transcripts, neurotransmitters, and post-translational and epigenetic modifications, are well-preserved and visualized. INSIHGT also allows multi-round molecular probing for high-dimensional spatial biology and compatibility with downstream traditional histology. With INSIHGT, we mapped previously undescribed podocyte-to-parietal epithelial cell microfilaments and demonstrated their geodesic clustering in mouse glomeruli, and catalogued sparsely located neurofilament-intensive inclusion bodies in the human cerebellum, and identified NPY-proximal cell types defined by spatial morpho-proteomics in mouse hypothalamus. We anticipate INSIHGT can form the foundations for 3D spatial multi-omics technology development and holistic systems biology studies.

bioengineering↗

bioRxiv2020

Genome-wide reversal of glial and neurovascular cell transcriptomic aging signatures by GLP-1R agonism

Pharmacological reversal of brain aging is a long-sought yet challenging strategy for the prevention and treatment of age-related neurodegeneration, due to the diverse cell types and complex cellular pathways impacted by the aging process. Here, we report the genome-wide reversal of transcriptomic aging signatures in multiple major brain cell types, including glial and mural cells, by glucagon-like peptide-1 receptor (GLP-1R) agonist (GLP-1RA) treatment. The age-related expression changes reversed by GLP-1RA encompass both shared and cell type-specific functional pathways that are implicated in aging and neurodegeneration. Concomitantly, Alzheimers disease (AD)-associated transcriptomic signature in microglia that arises from aging is reduced. These results show the feasibility of reversing brain aging by pharmacological means, provide mechanistic insights into the neurological benefits of GLP-1RAs in diabetic patients, and imply that GLP-1R agonism may be a generally applicable pharmacological intervention for patients at risk of age-related neurodegeneration.

neuroscience↗

bioRxiv2019

Genome-wide copy number variation-, validation- and screening study implicates a novel copy number polymorphism associated with suicide attempts in major depressive disorder

BackgroundThe genetic basis of suicide attempts (SA) remained unclear, especially for the copy number variations (CNVs) involved. The present study aimed to identify the susceptibility variants associated with SA among major depressive disorder (MDD) patients in Chinese, covering both single-nucleotide polymorphisms and CNVs. MethodsWe conducted GWAS on MDD patients with or without SA and top results were tested in a replication study. A genome-wide CNV study was performed. Subsequently, a validation assay using the qRT-PCR technology was performed to confirm the existence of the associated CNV and then applied to the entire cohort to examine the association. ResultsIn CNV analysis, we found that the global rate of CNV was higher in SA compared to non-SA subjects (p=0.023). The genome-wide CNV study revealed a SA-associated CNV region that achieved genome-wide significance (corrected p-value=0.014). The associated CNV was successfully validated and identified to be a common variant in this cohort and its deletion rate was higher in suicide attempters (OR=2.05). Based on the GTEx database, genetic variants that probe this CNV was significantly associated with the expression level of ZNF33B in two brain regions (p-value<4.2e-05). Besides, there was a significant interaction between neuroticism and the CNV in affecting suicidal risk; the CNV showed a significant effect (OR=2.58) in subjects with high neuroticism only. ConclusionsWe identified a new common CNV that may be involved in the etiology of SA. These findings imply an important role of common CNVs in the etiology of SA, which suggests a new promising avenue for investigating the genetic architecture of SA.

genetics↗